What does high ALT mean?

High ALT levels indicate liver cell damage or inflammation, with normal ranges typically 7-56 U/L for men and 7-45 U/L for women. Elevated ALT can result from various conditions including fatty liver disease, hepatitis, medications, or lifestyle factors, requiring medical evaluation to determine the underlying cause.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding ALT and Its Role in Your Body

Alanine aminotransferase (ALT) is an enzyme found primarily in your liver cells, with smaller amounts in your kidneys, heart, and muscles. This enzyme plays a crucial role in amino acid metabolism, helping convert alanine into pyruvate, which your body uses for energy production. When liver cells are damaged or inflamed, ALT leaks into your bloodstream, making it one of the most sensitive indicators of liver health.

ALT is often measured alongside AST (aspartate aminotransferase) as part of a comprehensive metabolic panel or liver function test. While both enzymes can indicate liver problems, ALT is more specific to liver damage, whereas AST is found in higher concentrations in other organs like the heart and muscles. The ratio of AST to ALT can provide additional insights into the type and severity of liver damage.

Normal vs. High ALT Levels

Normal ALT levels vary slightly between laboratories and can be influenced by factors like age, sex, and body mass index. Generally accepted normal ranges are:

ALT Elevation Categories and Clinical Significance

ULN = Upper Limit of Normal. These ranges are general guidelines; clinical context is essential for interpretation.
ALT LevelCategoryCommon CausesRecommended Action
< 2x ULN< 2x ULN (56-112 U/L men)Mild elevationNAFLD, medications, alcoholLifestyle changes, recheck in 3-6 months
2-5x ULN2-5x ULN (112-280 U/L men)Moderate elevationChronic hepatitis, NASH, autoimmuneComprehensive evaluation, treat underlying cause
5-10x ULN5-10x ULN (280-560 U/L men)Marked elevationAcute hepatitis, drug injuryUrgent evaluation, consider hospitalization
> 10x ULN> 10x ULN (>560 U/L men)Severe elevationAcute viral hepatitis, ischemia, toxinsImmediate medical attention required

ULN = Upper Limit of Normal. These ranges are general guidelines; clinical context is essential for interpretation.

  • Men: 7-56 units per liter (U/L)
  • Women: 7-45 units per liter (U/L)
  • Children: May have slightly higher normal ranges

However, recent research suggests that optimal ALT levels may be lower than these traditional ranges. Some experts recommend aiming for ALT levels below 30 U/L for men and below 25 U/L for women, as even modestly elevated levels within the 'normal' range may indicate early liver dysfunction. Understanding your baseline ALT levels through regular monitoring can help you detect changes early and take preventive action.

ALT levels are categorized based on how much they exceed the upper limit of normal (ULN). Understanding these categories helps determine the urgency and type of medical evaluation needed.

Common Causes of Elevated ALT

The most common cause of persistently elevated ALT in developed countries is non-alcoholic fatty liver disease (NAFLD), affecting approximately 25-30% of adults. NAFLD occurs when excess fat accumulates in liver cells, often associated with obesity, insulin resistance, and metabolic syndrome. Without intervention, NAFLD can progress to non-alcoholic steatohepatitis (NASH), characterized by inflammation and potential scarring.

Viral hepatitis remains a significant cause of elevated ALT worldwide. Hepatitis B and C can cause chronic liver inflammation, leading to persistently elevated ALT levels. Acute hepatitis A, while typically self-limiting, can cause dramatic ALT elevations exceeding 1000 U/L. Autoimmune hepatitis, where the immune system attacks liver cells, also presents with elevated ALT and requires prompt diagnosis and treatment.

Alcoholic liver disease develops from chronic alcohol consumption and can range from fatty liver to alcoholic hepatitis and cirrhosis. Even moderate alcohol intake can elevate ALT levels in susceptible individuals. The pattern of enzyme elevation, with AST typically higher than ALT, can help distinguish alcoholic from non-alcoholic liver disease.

Numerous medications can cause drug-induced liver injury (DILI), leading to elevated ALT levels. Common culprits include:

  • Acetaminophen (especially in high doses or with alcohol)
  • Statins (cholesterol-lowering medications)
  • Certain antibiotics (amoxicillin-clavulanate, isoniazid)
  • Anti-seizure medications (valproic acid, phenytoin)
  • NSAIDs (when used long-term or in high doses)

Herbal supplements and over-the-counter products aren't always benign. Green tea extract, kava, and certain weight loss supplements have been associated with liver injury and elevated ALT. Always inform your healthcare provider about all medications and supplements you're taking, as drug-induced liver injury is often reversible with prompt discontinuation.

Metabolic and Other Causes

Several metabolic conditions can elevate ALT levels. Hemochromatosis, a genetic disorder causing iron overload, leads to iron deposition in the liver and subsequent damage. Wilson's disease, characterized by copper accumulation, can present with elevated liver enzymes in younger individuals. Alpha-1 antitrypsin deficiency, another genetic condition, can cause both liver and lung disease.

Other causes include celiac disease (even without gastrointestinal symptoms), thyroid disorders, and muscle diseases. Intense exercise can temporarily elevate ALT by causing muscle breakdown, though this elevation is usually mild and transient. Pregnancy-related conditions like HELLP syndrome can cause significant ALT elevation and require immediate medical attention.

Symptoms Associated with High ALT

Many people with mildly elevated ALT levels experience no symptoms, which is why routine blood testing is valuable for early detection. However, as liver damage progresses or ALT levels rise significantly, various symptoms may develop:

  • Fatigue and weakness (often the first symptom)
  • Right upper abdominal discomfort or pain
  • Nausea and loss of appetite
  • Unexplained weight loss
  • Jaundice (yellowing of skin and eyes)
  • Dark urine and pale stools
  • Itchy skin (pruritus)
  • Swelling in legs and abdomen (in advanced cases)

The absence of symptoms doesn't mean elevated ALT is harmless. Liver disease often progresses silently until significant damage occurs. This makes regular monitoring through comprehensive blood testing essential for maintaining optimal liver health and catching problems early when they're most treatable.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Approach to Elevated ALT

When ALT levels are elevated, healthcare providers follow a systematic approach to determine the underlying cause. The first step involves confirming the elevation with repeat testing, as ALT can fluctuate due to various factors. A comprehensive metabolic panel including other liver enzymes (AST, alkaline phosphatase, GGT), bilirubin, and albumin provides a complete picture of liver function.

Additional testing may include:

  • Viral hepatitis serologies (hepatitis B and C)
  • Iron studies (ferritin, transferrin saturation) for hemochromatosis
  • Autoimmune markers (ANA, anti-smooth muscle antibodies)
  • Ceruloplasmin for Wilson's disease
  • Alpha-1 antitrypsin levels
  • Thyroid function tests
  • Celiac antibodies

Imaging studies like ultrasound can detect fatty liver, cirrhosis, or masses. More advanced imaging with CT or MRI may be necessary in certain cases. Liver biopsy, while invasive, remains the gold standard for diagnosing and staging many liver diseases, particularly when non-invasive tests are inconclusive.

Treatment Strategies for Lowering ALT

Lifestyle Modifications

For many causes of elevated ALT, particularly NAFLD, lifestyle changes form the cornerstone of treatment. Weight loss of 5-10% can significantly improve liver enzymes and reduce liver fat. This should be achieved through sustainable dietary changes and increased physical activity rather than crash diets, which can paradoxically worsen liver inflammation.

Dietary recommendations include:

  • Following a Mediterranean-style diet rich in vegetables, fruits, whole grains, and healthy fats
  • Limiting saturated fats and avoiding trans fats
  • Reducing added sugars and refined carbohydrates
  • Moderating portion sizes
  • Avoiding alcohol completely or limiting to recommended levels

Regular physical activity improves insulin sensitivity and helps reduce liver fat. Aim for at least 150 minutes of moderate-intensity exercise weekly, combining aerobic activities with resistance training. Even without weight loss, exercise can improve liver health and lower ALT levels.

Medical Management

Treatment of underlying conditions is essential for normalizing ALT levels. For viral hepatitis, antiviral medications can achieve sustained virologic response and normalize liver enzymes. Autoimmune hepatitis requires immunosuppressive therapy, typically with corticosteroids and azathioprine. Metabolic conditions like hemochromatosis are managed with phlebotomy or chelation therapy.

While no medications are specifically approved for NAFLD, certain drugs may help. Vitamin E (800 IU daily) has shown benefit in non-diabetic adults with NASH. Pioglitazone may improve liver histology in patients with diabetes. GLP-1 agonists and SGLT2 inhibitors, primarily used for diabetes, show promise in reducing liver fat and inflammation.

Monitoring and Long-term Management

Regular monitoring of ALT levels helps track treatment response and disease progression. The frequency of testing depends on the underlying cause and initial ALT elevation. For mild elevations with identified reversible causes, retesting in 3-6 months may be appropriate. More severe elevations or progressive liver disease require closer monitoring.

Long-term management focuses on preventing progression to cirrhosis and reducing complications. This includes:

  • Maintaining a healthy weight and active lifestyle
  • Managing comorbid conditions (diabetes, hypertension, dyslipidemia)
  • Avoiding hepatotoxic substances
  • Vaccinating against hepatitis A and B if not immune
  • Regular screening for liver cancer in high-risk individuals

Comprehensive metabolic monitoring through regular blood testing allows you to track not just ALT but related markers that impact liver health, including glucose, lipids, and inflammatory markers. This holistic approach enables early intervention and helps prevent progression of liver disease.

The Importance of Early Detection and Action

Elevated ALT represents an opportunity for early intervention before irreversible liver damage occurs. The liver has remarkable regenerative capacity, and many causes of elevated ALT are reversible with appropriate treatment. However, chronic inflammation can lead to fibrosis and eventually cirrhosis, at which point options become limited.

Taking a proactive approach to liver health involves regular screening, especially if you have risk factors like obesity, diabetes, or family history of liver disease. Understanding your ALT levels in the context of other biomarkers provides valuable insights into your overall metabolic health. By identifying and addressing elevated ALT early, you can prevent progression to serious liver disease and maintain optimal health for years to come.

References

  1. Kwo, P. Y., Cohen, S. M., & Lim, J. K. (2017). ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology, 112(1), 18-35.[Link][PubMed][DOI]
  2. Younossi, Z. M., et al. (2018). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84.[PubMed][DOI]
  3. Chalasani, N., et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328-357.[Link][PubMed][DOI]
  4. Newsome, P. N., et al. (2018). Guidelines on the management of abnormal liver blood tests. Gut, 67(1), 6-19.[Link][PubMed][DOI]
  5. Vilar-Gomez, E., et al. (2015). Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology, 149(2), 367-378.[PubMed][DOI]
  6. European Association for the Study of the Liver (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology, 75(3), 659-689.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ALT at home?

You can test your ALT at home with SiPhox Health's Heart & Metabolic Program, which includes ALT testing along with other liver enzymes like AST. The Core Health Program offers ALT testing through the Metabolic+ expansion, providing comprehensive liver function assessment from the comfort of your home.

How quickly can ALT levels return to normal?

ALT levels can normalize within weeks to months depending on the cause. Medication-induced elevations often resolve within 2-4 weeks after stopping the offending drug. Lifestyle-related elevations from fatty liver may take 3-6 months of consistent diet and exercise changes. Viral hepatitis treatment can normalize levels within 12-24 weeks.

What foods should I avoid with high ALT?

Avoid alcohol, high-fructose corn syrup, processed foods high in saturated fats, and excessive amounts of red meat. Limit foods with added sugars, refined carbohydrates, and fried foods. Focus instead on whole grains, lean proteins, fruits, vegetables, and foods rich in omega-3 fatty acids like fish and walnuts.

Can exercise temporarily raise ALT levels?

Yes, intense exercise can temporarily elevate ALT levels due to muscle breakdown, typically peaking 24-48 hours after exercise. These elevations are usually mild (less than 2-3 times normal) and resolve within a week. If you're getting blood work done, avoid intense exercise for 48-72 hours beforehand for accurate results.

When should I be concerned about my ALT levels?

Seek medical evaluation if ALT is more than twice the upper limit of normal, if levels are persistently elevated on repeat testing, or if you have symptoms like jaundice, severe fatigue, or abdominal pain. Any ALT elevation in the context of new medications or supplements also warrants prompt medical attention.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details